Bashir Hamidi

Dr. Bashir Hamidi


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2016 in Journal of Medical Internet Research
Verified
Journal Article
Open access
AKAbby Swanson Kazley
Abby Swanson Kazley
BHBashir Hamidi
Bashir Hamidi
WBWendy Balliet
Wendy Balliet
PBPrabhakar Baliga
Prabhakar Baliga
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

11 July 2019 in Genes
Verified
Journal Article
Open access
PDF file
BHBashir Hamidi
Bashir Hamidi
KWKristin Wallace
Kristin Wallace
AAAlexander Alekseyenko
Alexander Alekseyenko
Many important exposure–response relationships, such as diet and weight, can be influenced by intermediates, such as the gut microbiome. Understanding the role of these intermediates, the mediators, is important in refining cause–effect theories and discovering additional medical interventions (e.g., probiotics, prebiotics). Mediation analysis has been at the heart of behavioral health research, rapidly gaining popularity with the biomedical sciences in the last decade. A specific analytic challenge is being able to incorporate an entire ’omics assay as a mediator. To address this challenge, we propose a hypothesis testing framework for multivariate omnibus distance mediation analysis (MODIMA). We use the power of energy statistics, such as partial distance correlation, to allow for analysis of multivariate exposure–mediator–response triples. Our simulation results demonstrate the favorable statistical properties of our approach relative to the available alternatives. Finally, we demonstrate the application of the proposed methods in two previously published microbiome datasets. Our framework adds a new tool to the toolbox of approaches to the integration of ‘omics big data.

15 October 2024 in JMIR Medical Informatics
Verified
Journal Article
Open access
Abe MollaloAbe Mollalo
Abe Mollalo
BHBashir Hamidi
Bashir Hamidi
LLLeslie A Lenert
Leslie A Lenert
AAAlexander Alekseyenko
Alexander Alekseyenko
Background: Electronic health records (EHRs) commonly contain patient addresses that provide valuable data for geocoding and spatial analysis, enabling more comprehensive descriptions of individual patients for clinical purposes. Despite the widespread use of EHRs in clinical decision support and interventions, no systematic review has examined the extent to which spatial analysis is used to characterize patient phenotypes. Objective: This study reviews advanced spatial analyses that used individual-level health data from EHRs within the United States to characterize patient phenotypes. Methods: We systematically evaluated English-language, peer-reviewed studies from the PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar databases from inception to August 20, 2023, without imposing constraints on study design or specific health domains. Results: A substantial proportion of studies (>85%) were limited to geocoding or basic mapping without implementing advanced spatial statistical analysis, leaving only 49 studies that met the eligibility criteria. These studies used diverse spatial methods, with a predominant focus on clustering techniques, while spatiotemporal analysis (frequentist and Bayesian) and modeling were less common. A noteworthy surge (n=42, 86%) in publications was observed after 2017. The publications investigated a variety of adult and pediatric clinical areas, including infectious disease, endocrinology, and cardiology, using phenotypes defined over a range of data domains such as demographics, diagnoses, and visits. The primary health outcomes investigated were asthma, hypertension, and diabetes. Notably, patient phenotypes involving genomics, imaging, and notes were limited. Conclusions: This review underscores the growing interest in spatial analysis of EHR-derived data and highlights knowledge gaps in clinical health, phenotype domains, and spatial methodologies. We suggest that future research should focus on addressing these gaps and harnessing spatial analysis to enhance individual patient contexts and clinical decision support.

7 September 2022 in Journal of the American Medical Informatics Association
Verified
Journal Article
Open access
PDF file
BHBashir Hamidi
Bashir Hamidi
PFPatrick A Flume
Patrick A Flume
KSKit N Simpson
Kit N Simpson
AAAlexander Alekseyenko
Alexander Alekseyenko
Electronic (e)-phenotype specification by noninformaticist investigators remains a challenge. Although validation of each patient returned by e-phenotype could ensure accuracy of cohort representation, this approach is not practical. Understanding the factors leading to successful e-phenotype specification may reveal generalizable strategies leading to better results. Noninformaticist experts (n = 21) were recruited to produce expert-mediated e-phenotypes using i2b2 assisted by a honest data-broker and a project coordinator. Patient- and visit-sets were reidentified and a random sample of 20 charts matching each e-phenotype was returned to experts for chart-validation. Attributes of the queries and expert characteristics were captured and related to chart-validation rates using generalized linear regression models. E-phenotype validation rates varied according to experts’ domains and query characteristics (mean = 61%, range 20–100%). Clinical domains that performed better included infectious, rheumatic, neonatal, and cancers, whereas other domains performed worse (psychiatric, GI, skin, and pulmonary). Match-rate was negatively impacted when specification of temporal constraints was required. In general, the increase in e-phenotype specificity contributed positively to match-rate. Clinical experts and informaticists experience a variety of challenges when building e-phenotypes, including the inability to differentiate clinical events from patient characteristics or appropriately configure temporal constraints; a lack of access to available and quality data; and difficulty in specifying routes of medication administration. Biomedical query mediation by informaticists and honest data-brokers in designing e-phenotypes cannot be overstated. Although tools such as i2b2 may be widely available to noninformaticists, successful utilization depends not on users’ confidence, but rather on creating highly specific e-phenotypes.

9 November 2020 in Journal of the American Medical Informatics Association
Verified
Journal Article
Open access
PDF file
AAAlexander Alekseyenko
Alexander Alekseyenko
BHBashir Hamidi
Bashir Hamidi
TFTrevor D Faith
Trevor D Faith
Keith A. CrandallKeith A. Crandall
Keith A. Crandall
JPJennifer G Powers
Jennifer G Powers
LLLeslie A Lenert
Leslie A Lenert
The ability to analyze human specimens is the pillar of modern-day translational research. To enhance the research availability of relevant clinical specimens, we developed the Living BioBank (LBB) solution, which allows for just-in-time capture and delivery of phenotyped surplus laboratory medicine specimens. The LBB is a system-of-systems integrating research feasibility databases in i2b2, a real-time clinical data warehouse, and an informatics system for institutional research services management (SPARC). LBB delivers deidentified clinical data and laboratory specimens. We further present an extension to our solution, the Living µBiome Bank, that allows the user to request and receive phenotyped specimen microbiome data. We discuss the details of the implementation of the LBB system and the necessary regulatory oversight for this solution. The conducted institutional focus group of translational investigators indicates an overall positive sentiment towards potential scientific results generated with the use of LBB. Reference implementation of LBB is available at https://LivingBioBank.musc.edu.

10 December 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
BHBashir Hamidi
Bashir Hamidi
KWKristin Wallace
Kristin Wallace
CVChenthamarakshan Vasu
Chenthamarakshan Vasu
AAAlexander Alekseyenko
Alexander Alekseyenko
Background: Community-wide analyses provide an essential means for evaluation of the effect of interventions or design variables on the composition of the microbiome. Applications of these analyses are omnipresent in microbiome literature, yet some of their statistical properties have not been tested for robustness towards common features of microbiome data. Recently, it has been reported that PERMANOVA can yield wrong results in the presence of heteroscedasticity and unbalanced sample sizes. Findings: We develop a method for multivariate analysis of variance, , based on Welch MANOVA that is robust to heteroscedasticity in the data. We do so by extending a previously reported method that does the same for two-level independent factor variables. Our approach can accommodate multi-level factors, stratification, and multiple post hoc testing scenarios. An R language implementation of the method is available at https://github.com/alekseyenko/WdStar . Conclusion: Our method resolves potential for confounding of location and dispersion effects in multivariate analyses by explicitly accounting for the differences in multivariate dispersion in the data tested. The methods based on have general applicability in microbiome and other ‘omics data analyses.